Diabetes

Dapagliflozin improves glucose outcomes in type 1 diabetes

(HealthDay)—In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care.

Diseases, Conditions, Syndromes

New gene variant is even more resistant to hospital antiseptic

A team of investigators has discovered a new, more powerful variant on an antimicrobial resistance gene common among Staphylococcus species. The gene protects the bacteria from an antiseptic compound widely used in healthcare. ...

Medications

FDA warns against use of preowned or unauthorized test strips

(HealthDay)—The U.S. Food and Drug Administration is warning patients not to use preowned test strips or test strips not authorized for sale in the United States because of possible infection or inaccurate results that ...

Cardiology

Mobile device to provide instant diagnosis of heart diseases

Cardiovascular diseases (CVDs) continue to be a leading cause of death. According to the World Health Organization, more people die annually from CVDs than from any other cause. Since their diagnosis might require specialised ...

Health

FDA chief Scott Gottlieb steps down after nearly 2 years

Food and Drug Administration Commissioner Scott Gottlieb is stepping down after nearly two years leading the agency's response to a host of public health challenges, including the opioid epidemic, rising drug prices and underage ...

page 31 from 40